Dolishale 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Dolishale 28 Day (Levonorgestrel 90 mcg / Ethinyl Estradiol 20 mcg), a continuous combined oral contraceptive manufactured by Ingenus Pharmaceuticals, has experienced intermittent availability challenges that are affecting patient access. This briefing provides an overview of the current supply situation, prescribing considerations, and resources to support your patients.

Shortage Timeline and Current Status

Oral contraceptive supply disruptions have been reported intermittently since 2020, affecting multiple brands and formulations across the combined hormonal contraceptive category. Dolishale 28 Day, as a continuous-dose formulation with limited manufacturers, has been particularly susceptible to these disruptions.

As of early 2026, the situation remains inconsistent. Some geographic regions and pharmacy chains report adequate stock, while others experience recurring shortfalls. The shortage is not typically listed on the FDA's formal shortage database, as Ingenus Pharmaceuticals has not reported a manufacturing cessation. However, distribution-level constraints and demand fluctuations continue to create gaps at the retail level.

Prescribing Implications

The intermittent availability of Dolishale 28 Day raises several clinical considerations for prescribers:

• Contraceptive continuity risk — Patients on continuous oral contraceptives face a higher risk from gaps in therapy than those on cyclic regimens, as there is no built-in hormone-free interval. Even a few missed days can trigger breakthrough bleeding and reduce contraceptive efficacy.
• Patient anxiety and adherence — Patients who have difficulty finding their specific brand may experience anxiety about unintended pregnancy or symptom recurrence (particularly those using Dolishale off-label for PMDD, endometriosis, or menstrual migraines). This can impact adherence if patients lose confidence in their ability to maintain uninterrupted access.
• Generic substitution considerations — Amethyst (also Levonorgestrel 90 mcg / Ethinyl Estradiol 20 mcg continuous) is an AB-rated generic equivalent that pharmacists can typically substitute without a new prescription. However, patients should be informed about the substitution, as brand name changes can cause confusion about whether they're taking the correct medication.
• Hormonal exposure differences — As noted in the prescribing information, Dolishale provides 13 additional weeks of hormone exposure per year compared to conventional cyclic oral contraceptives containing the same strength hormones. This should be factored into risk-benefit discussions, particularly for patients with cardiovascular risk factors.

Current Availability Picture

The availability of Dolishale 28 Day varies by region and pharmacy. Key observations include:

• Large chain pharmacies may not stock Dolishale regularly due to distributor contracts and may default to Amethyst or other Levonorgestrel/Ethinyl Estradiol products.
• Independent pharmacies with access to multiple wholesalers may have better luck sourcing the product.
• Mail-order pharmacies associated with insurance plans sometimes maintain more consistent inventory for maintenance medications.

Cost and Access Considerations

Under the ACA contraceptive mandate, most insurance plans cover Dolishale 28 Day and its generic equivalents at no cost-sharing to the patient. For uninsured or underinsured patients:

• Cash price ranges from approximately $57 to $69 per 28-day pack.
• Discount card programs (GoodRx, SingleCare) can reduce costs to $7-$21 per pack.
• Patient assistance programs through NeedyMeds and RxAssist may help patients with financial hardship.
• Planned Parenthood and federally qualified health centers (FQHCs) can provide low-cost or free contraceptives to eligible patients.

Tools and Resources for Providers

Medfinder for Providers — Medfinder.com/providers offers tools to help you and your clinical staff check real-time pharmacy availability for Dolishale 28 Day and its equivalents. You can direct patients to the platform to search for pharmacies with stock in their area, reducing the burden on your front office staff.

Additional resources for your practice:

• FDA Drug Shortages Database — Monitor for formal shortage announcements at FDA.gov.
• ASHP Drug Shortage Resource Center — Provides clinical guidance for managing drug shortages.
• Pharmacy benefits manager (PBM) contacts — Work with your patients' PBMs to identify covered alternatives if Dolishale is unavailable.

Therapeutic Alternatives to Consider

When Dolishale 28 Day is unavailable, the following alternatives may be appropriate depending on your patient's clinical profile:

• Amethyst — AB-rated generic equivalent (Levonorgestrel 90 mcg / Ethinyl Estradiol 20 mcg, continuous). Direct substitution typically requires no new prescription.
• Seasonale / Seasonique — Extended-cycle 91-day packs (Levonorgestrel / Ethinyl Estradiol). Patients have four withdrawal periods per year. May be more widely available.
• Aviane or equivalent cyclic regimen used continuously — Prescribing a standard 28-day Levonorgestrel/Ethinyl Estradiol pack (e.g., Aviane 100 mcg/20 mcg) with instructions to skip the placebo week is a well-established off-label approach to continuous contraception. Note the slightly higher Levonorgestrel dose (100 mcg vs. 90 mcg).
• NuvaRing (Etonogestrel/Ethinyl Estradiol vaginal ring) — A non-oral option for patients open to a different delivery method. Can also be used continuously by replacing the ring immediately without a ring-free interval.

Looking Ahead

The continuous oral contraceptive segment remains a relatively small part of the overall OC market, which limits manufacturer investment and competition. Until additional manufacturers enter the space or supply chains stabilize further, intermittent availability is likely to persist. Proactive prescribing strategies — including noting acceptable substitutions on prescriptions and discussing alternatives in advance — can help mitigate the impact on patient care.

Final Thoughts

The Dolishale 28 Day shortage requires a proactive approach from prescribers. By familiarizing yourself with therapeutic alternatives, noting acceptable substitutions on prescriptions, and connecting patients with tools like Medfinder for Providers, you can help ensure continuity of care during supply disruptions. For a step-by-step workflow guide, see our article on how to help your patients find Dolishale 28 Day in stock.